John L. Higgins, Director at Ligand Pharma, holds 36.61K shares in Bio-Techne (Ticker: TECH), holds 2.35M shares in OmniAb (Ticker: OABI), holds 417.69K shares in Ligand Pharma (Ticker: LGND). Most recently, John L. Higgins Sold ― shares of Bio-Techne on May 16, 2024 for an estimated value of 335.36K.